When this SCLC cohort was divided into good and poor prognosis groups, TTF‐1‐regulated genes were significantly enriched in the poor prognosis group (Fig. 5I), which also suggested the tumor‐promoting role of TTF‐1 in clinical SCLC tumors. The gene discussed is TTF1; the disease is neoplasm.